Lv1
70 积分 2023-11-18 加入
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer
1个月前
已完结
Interleukin-6 confers radio-resistance by inducing Akt mediated glycolysis and reducing mitochondrial damage in cells
1个月前
已完结
A causal link from ALK to hexokinase II overexpression and hyperactive glycolysis in EML4-ALK-positive lung cancer
2个月前
已关闭
ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3
2个月前
已完结
HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness
3个月前
已完结
Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management
4个月前
已完结
Acquired Resistance to a New Alk Inhibitor, Alectinib in Lung Cancer
4个月前
已完结
Abstract 4548: Discovering novel ALK-lung carcinoma therapeutic strategies by identifying combinations with Alectinib from ALK-positive lung carcinoma cell lines
4个月前
已关闭
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC
6个月前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
9个月前
已完结
皖公网安备34019202002308
